Next Article in Journal
The Emerging Role of ESR1 Mutations in Luminal Breast Cancer as a Prognostic and Predictive Biomarker of Response to Endocrine Therapy
Next Article in Special Issue
5-Fluorouracil as a Tumor-Treating Field-Sensitizer in Colon Cancer Therapy
Previous Article in Journal
Recurrent or Refractory High-Grade Gliomas Treated by Convection-Enhanced Delivery of a TGFβ2-Targeting RNA Therapeutic: A Post-Hoc Analysis with Long-Term Follow-Up
Previous Article in Special Issue
FoxO3a as a Positive Prognostic Marker and a Therapeutic Target in Tamoxifen-Resistant Breast Cancer
 
 
Article

Article Versions Notes

Cancers 2019, 11(12), 1893; https://doi.org/10.3390/cancers11121893
Action Date Notes Link
article xml file uploaded 28 November 2019 10:26 CET Original file -
article xml uploaded. 28 November 2019 10:26 CET Update https://www.mdpi.com/2072-6694/11/12/1893/xml
article pdf uploaded. 28 November 2019 10:26 CET Version of Record https://www.mdpi.com/2072-6694/11/12/1893/pdf
article html file updated 28 November 2019 10:28 CET Original file -
article html file updated 30 December 2019 14:08 CET Update -
article html file updated 14 February 2020 13:52 CET Update -
article html file updated 19 July 2022 22:56 CEST Update https://www.mdpi.com/2072-6694/11/12/1893/html
Back to TopTop